Suppr超能文献

双能 CT 在肾上腺腺瘤与转移瘤鉴别中的应用:物质密度图和单能量图像的作用。

Dual-energy CT in the differentiation between adrenal adenomas and metastases: Usefulness of material density maps and monochromatic images.

机构信息

Servicio de Diagnóstico por la Imagen, Hospital Universitario QuironSalud, Pozuelo de Alarcón, Madrid, Spain.

Servicio de Diagnóstico por la Imagen, Hospital Universitario QuironSalud, Pozuelo de Alarcón, Madrid, Spain.

出版信息

Radiologia (Engl Ed). 2023 Sep-Oct;65(5):402-413. doi: 10.1016/j.rxeng.2021.10.006. Epub 2023 Sep 12.

Abstract

OBJECTIVE

To evaluate the behavior of adrenal adenomas and metastases with dual-energy CT, analyzing the attenuation coefficient in monochromatic images at three different levels of energy (45, 70, and 140 keV) and the tissue concentrations of fat, water, and iodine in material density maps, with the aim of establishing optimal cutoffs for differentiating between these lesions and comparing our results against published evidence.

MATERIALS AND METHODS

This retrospective case-control study included oncologic patients diagnosed with adrenal metastases in the 6-12 months prior to the study who were followed up in our hospital between January and June 2020. For each case (patient with metastases) included in the study, we selected a control (patient with an adrenal adenoma) with a nodule of similar size. All patients were studied with a rapid-kilovoltage-switching dual-energy CT scanner, using a biphasic acquisition protocol. We analyzed the concentration of iodine in paired water-iodine images, the concentration of fat in the paired water-fat images, and the concentration of water in the paired iodine-water and fat-water images, in both the arterial and portal phases. We also analyzed the attenuation coefficient in monochromatic images (at 55, 70, and 140 keV) in the arterial and portal phases.

RESULTS

In the monochromatic images, in both the arterial and portal phases, the attenuation coefficient at all energy levels was significantly higher in the group of patients with metastases than in the group of patients with adenomas. This enabled us to calculate the optimal cutoffs for classifying lesions as adenomas or metastases, except for the arterial phase at 55 KeV, where the area under the receiver operating characteristic curve (AUC) for the estimated threshold (0.68) was not considered accurate enough to classify the lesions. For the arterial phase at 70 keV, the AUC was 0.76 (95% CI: 0.663‒0.899); the optimal cutoff (42.4 HU) yielded 92% sensitivity and 60% specificity. For the arterial phase at 140 keV, the AUC was 0.94 (95% CI: 0.894‒0.999); the optimal cutoff (18.9 HU) yielded 88% sensitivity and 94% specificity). For the portal phase at 55 keV, the AUC was 0.76 (95% CI: 0.663‒0.899); the optimal cutoff (95.4 HU) yielded 68% sensitivity and 84% specificity. For the portal phase at 70 keV, the AUC was 0.82 (95% CI: 0.757‒0.955); the optimal cutoff (58.4 HU) yielded 80% sensitivity and 84% specificity. For the portal phase at 140 keV, the AUC was 0.9 (95% CI: 0.834‒0.987); the optimal cutoff (16.35 HU) yielded 96% sensitivity and 84% specificity. In the material density maps, in the arterial phase, significant differences were found only for the iodine-water pair, where the concentration of water was higher in the group with metastases (1018.8 ± 7.6 mg/cm vs. 998.6 ± 8.0 mg/cm for the group with adenomas, p < 0.001). The AUC was 0.97 (95% CI: 0.893‒0.999); the optimal cutoff (1012.5 mg/cm) yielded 88% sensitivity and 96% specificity. The iodine-water pair was also significantly higher in metastases (1019.7 ± 12.1 mg/cm vs. 998.5 ± 9.1 mg/cm in adenomas, p < 0.001). The AUC was 0.926 (95% CI: 0.807‒0.977); the optimal cutoff (1009.5 mg/cm) yielded 92% sensitivity and 92% specificity. Although significant results were also observed for the fat-water pair in the portal phase, the AUC was insufficient to enable a sufficiently accurate cutoff for classifying the lesions. No significant differences were found in the fat-water maps or iodine-water maps in the arterial or portal phase or in the water-fat map in the arterial phase.

CONCLUSIONS

Monochromatic images show differences between the behavior of adrenal adenomas and metastases in oncologic patients studied with intravenous-contrast-enhanced CT, where the group of metastases had higher attenuation than the group of adenomas in both the arterial and portal phases; this pattern is in line with the evidence published for adenomas. Nevertheless, to our knowledge, no other publications report cutoffs for this kind of differentiation in contrast-enhanced monochromatic images obtained in rapid-kilovoltage-switching dual-energy CT scanners, and this is the first new contribution of our study. Regarding the material density maps, our results suggest that the water-iodine pair is a good tool for differentiating between adrenal adenomas and metastases, in both the arterial and portal phases. We propose cutoffs for differentiating these lesions, although to our knowledge no cutoffs have been proposed for portal-phase contrast-enhanced images obtained with rapid-kilovoltage-switching dual-energy CT scanners.

摘要

目的

评估双能 CT 对肾上腺腺瘤和转移瘤的行为表现,分析三种不同能量水平(45、70 和 140 keV)下单色图像的衰减系数以及物质密度图中的脂肪、水和碘的组织浓度,旨在为区分这些病变建立最佳截止值,并与已发表的证据进行比较。

材料和方法

本回顾性病例对照研究纳入了在研究前 6-12 个月在我院确诊为肾上腺转移瘤的肿瘤患者,在 2020 年 1 月至 6 月期间在我院进行了随访。为了对每个病例(转移瘤患者)进行研究,我们选择了一个大小相似的对照(肾上腺腺瘤患者)。所有患者均使用快速千伏切换双能 CT 扫描仪进行双期采集。我们分析了动、门静脉期水碘图中碘的浓度,水脂图中脂肪的浓度,碘水和脂水图中水的浓度。我们还分析了动、门静脉期单色图像(55、70 和 140 keV)中的衰减系数。

结果

在单色图像中,无论是在动脉期还是门静脉期,转移瘤组的所有能量水平的衰减系数均明显高于腺瘤组。这使我们能够计算出将病变分类为腺瘤或转移瘤的最佳截止值,除了动脉期 55 keV 外,该截止值的受试者工作特征曲线(ROC)下面积(0.68)不足以准确地对病变进行分类。对于 70 keV 的动脉期,ROC 曲线下面积(AUC)为 0.76(95%可信区间:0.663-0.899);最佳截断值(42.4 HU)的灵敏度为 92%,特异性为 60%。对于 140 keV 的动脉期,AUC 为 0.94(95%可信区间:0.894-0.999);最佳截断值(18.9 HU)的灵敏度为 88%,特异性为 94%。对于 55 keV 的门静脉期,AUC 为 0.76(95%可信区间:0.663-0.899);最佳截断值(95.4 HU)的灵敏度为 68%,特异性为 84%。对于 70 keV 的门静脉期,AUC 为 0.82(95%可信区间:0.757-0.955);最佳截断值(58.4 HU)的灵敏度为 80%,特异性为 84%。对于 140 keV 的门静脉期,AUC 为 0.9(95%可信区间:0.834-0.987);最佳截断值(16.35 HU)的灵敏度为 96%,特异性为 84%。在物质密度图中,仅在动脉期观察到碘水对的显著差异,转移瘤组的水浓度较高(转移瘤组为 1018.8±7.6 mg/cm,腺瘤组为 998.6±8.0 mg/cm,p<0.001)。AUC 为 0.97(95%可信区间:0.893-0.999);最佳截断值(1012.5 mg/cm)的灵敏度为 88%,特异性为 96%。碘水对在转移瘤中也明显更高(转移瘤组为 1019.7±12.1 mg/cm,腺瘤组为 998.5±9.1 mg/cm,p<0.001)。AUC 为 0.926(95%可信区间:0.807-0.977);最佳截断值(1009.5 mg/cm)的灵敏度为 92%,特异性为 92%。尽管在门静脉期也观察到脂肪水对的显著差异,但 AUC 不足以提供足够准确的截止值来对病变进行分类。在动脉期和门静脉期的脂肪水图或碘水图以及动脉期的水脂图中均未发现显著差异。

结论

在静脉内对比增强 CT 研究的肿瘤患者中,肾上腺腺瘤和转移瘤的行为表现存在差异,转移瘤组在动脉期和门静脉期的衰减系数均高于腺瘤组,这与已发表的关于腺瘤的证据一致。然而,据我们所知,目前尚无其他出版物报告过在快速千伏切换双能 CT 扫描仪获得的对比增强单色图像中区分这两种病变的截止值,这是我们研究的首次新贡献。关于物质密度图,我们的结果表明,在动、门静脉期,碘水对是区分肾上腺腺瘤和转移瘤的一个很好的工具。我们提出了区分这些病变的截止值,尽管据我们所知,目前还没有提出过用于快速千伏切换双能 CT 扫描仪获得的门静脉期对比增强图像的截止值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验